Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Cardinal Health (CAH)

Cardinal Health (CAH)
126.91 x 1 132.09 x 1
Post-market by (Cboe BZX)
129.63 -7.46 (-5.44%) 04/04/25 [NYSE]
126.91 x 1 132.09 x 1
Post-market 129.63 unch (unch) 17:28 ET
Quote Overview for Fri, Apr 4th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
128.77
Day High
136.21
Open 134.48
Previous Close 137.09 137.09
Volume 3,760,968 3,760,968
Avg Vol 2,486,594 2,486,594
Stochastic %K 61.45% 61.45%
Weighted Alpha +22.24 +22.24
5-Day Change -6.81 (-4.99%) -6.81 (-4.99%)
52-Week Range 93.17 - 139.50 93.17 - 139.50
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 33,116,556
  • Shares Outstanding, K 241,568
  • Annual Sales, $ 226,827 M
  • Annual Income, $ 852,000 K
  • EBIT $ 2,228 M
  • EBITDA $ 2,938 M
  • 60-Month Beta 0.61
  • Price/Sales 0.15
  • Price/Cash Flow 13.16
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 47.97% ( +12.36%)
  • Historical Volatility 23.52%
  • IV Percentile 100%
  • IV Rank 100.00%
  • IV High 47.97% on 04/04/25
  • IV Low 14.79% on 12/04/24
  • Put/Call Vol Ratio 25.64
  • Today's Volume 30,019
  • Volume Avg (30-Day) 11,542
  • Put/Call OI Ratio 1.48
  • Today's Open Interest 84,473
  • Open Int (30-Day) 64,511

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 2.15
  • Number of Estimates 8
  • High Estimate 2.22
  • Low Estimate 2.04
  • Prior Year 2.08
  • Growth Rate Est. (year over year) +3.37%

Price Performance

See More
Period Period Low Period High Performance
1-Month
122.26 +6.03%
on 03/10/25
Period Open: 126.31
139.50 -7.08%
on 04/03/25
+3.32 (+2.63%)
since 03/04/25
3-Month
119.00 +8.93%
on 01/06/25
Period Open: 119.30
139.50 -7.08%
on 04/03/25
+10.33 (+8.66%)
since 01/03/25
52-Week
93.17 +39.13%
on 07/15/24
Period Open: 110.12
139.50 -7.08%
on 04/03/25
+19.51 (+17.72%)
since 04/04/24

Most Recent Stories

More News
GEHC Stock Gains Following Buyout Completion to Boost Its PDx Arm

GE HealthCare Technologies Inc. GEHC, yesterday, announced the completion of its acquisition of the remaining 50% stake in Nihon Medi-Physics Co., Ltd (“NMP”) from Sumitomo Chemical, giving it full...

BSX : 89.70 (-8.93%)
COR : 278.39 (-3.79%)
GEHC : 60.51 (-15.96%)
CAH : 129.63 (-5.44%)
1 S&P 500 Stock with Exciting Potential and 2 to Ignore

1 S&P 500 Stock with Exciting Potential and 2 to Ignore

DRI : 192.38 (-4.14%)
CAH : 129.63 (-5.44%)
CHTR : 338.29 (-8.17%)
Cardinal Health Has a String of New Highs

Summary Cardinal Health (CAH) shows strong technical buy signals, with a 3.95% gain since the Trend Seeker buy signal on 3/18 and consistent price appreciation. The company operates globally, providing...

CAH : 129.63 (-5.44%)
Forget Tech: Buy These 5 Non-Tech High Flyers of Q1

Wall Street suffered due to volatility in the first quarter of 2025. U.S. stock markets are likely to close the first quarter on a negative note. This is in contrast to the last two years' performances. Out...

WEC : 104.36 (-3.84%)
CNP : 36.08 (-3.43%)
TPR : 62.94 (-3.30%)
CME : 254.46 (-5.18%)
CAH : 129.63 (-5.44%)
DXCM Stock Falls as FDA Warnings Raise Concern for 15-Day G7 Approval

DexCom DXCM is facing regulatory scrutiny following a warning letter recently posted by the FDA. This could affect the approval of the company’s upcoming 15-day G7 continuous glucose monitor (CGM). The...

BSX : 89.70 (-8.93%)
COR : 278.39 (-3.79%)
CAH : 129.63 (-5.44%)
DXCM : 59.83 (-3.19%)
DXCM Stock Gains Following New Data on Upcoming G7 CGM Sensor

DexCom, Inc. DXCM recently unveiled new data for its upcoming G7 15-day continuous glucose monitoring (CGM) sensor at the Advanced Technologies & Treatments for Diabetes (ATTD) conference 2025. With an...

BSX : 89.70 (-8.93%)
COR : 278.39 (-3.79%)
CAH : 129.63 (-5.44%)
DXCM : 59.83 (-3.19%)
BDX Stock Declines Following Class I Classification for Alaris Recall

Becton, Dickinson and Company’s BDX, or popularly known as BD, initiated the recall of its infusion pumps last month after customer reports indicated software issues, potentially leading to inaccurate...

BSX : 89.70 (-8.93%)
BDX : 207.34 (-6.43%)
COR : 278.39 (-3.79%)
CAH : 129.63 (-5.44%)
GEHC Stock Falls Despite New Launch to Boost Breast Cancer Diagnosis

GE HealthCare Technologies Inc. GEHC, on Thursday, announced the launch of the Invenia Automated Breast Ultrasound (ABUS) Premium. It is the latest 3D ultrasound product from the company, which is expected...

BSX : 89.70 (-8.93%)
COR : 278.39 (-3.79%)
GEHC : 60.51 (-15.96%)
CAH : 129.63 (-5.44%)
Cardinal Health Stock: Is CAH Outperforming the Healthcare Sector?

Cardinal Health has surpassed the broader healthcare sector’s performance over the past year, and analysts are expressing continued confidence in its growth potential.

XLV : 135.28 (-5.48%)
COR : 278.39 (-3.79%)
CAH : 129.63 (-5.44%)
Healthcare Providers & Services Stocks Q4 Teardown: Cardinal Health (NYSE:CAH) Vs The Rest

Healthcare Providers & Services Stocks Q4 Teardown: Cardinal Health (NYSE:CAH) Vs The Rest

OPCH : 33.54 (-4.01%)
AGL : 4.15 (+3.75%)
HCA : 331.65 (-5.01%)
ALHC : 18.11 (-2.16%)
CAH : 129.63 (-5.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and...

See More

Key Turning Points

3rd Resistance Point 141.74
2nd Resistance Point 138.98
1st Resistance Point 134.30
Last Price 129.63
1st Support Level 126.86
2nd Support Level 124.10
3rd Support Level 119.42

See More

52-Week High 139.50
Last Price 129.63
Fibonacci 61.8% 121.80
Fibonacci 50% 116.33
Fibonacci 38.2% 110.87
52-Week Low 93.17

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades